Tosedostat has been used in trials studying the treatment and supportive care of AML, Leukemia, Pancreas Cancer, Multiple Myeloma, and Pancreatic Cancer, among others. It is an inhibitor of the M1 family of aminopeptidases, in particular PuSA, and LTA4 hydrolase.Reference standards of Tosedostat API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Tosedostat - API Standards [catalogue_number] => PA 73 18000 [category_ids] => ,79,80,69,81,78,70,82, [chemical_name] => [weight] => 406.47 [form] => C21H30N2O6 [cas] => 238750-77-1 [pslug] => 238750-77-1-tosedostat-api-pa7318000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 73 18000
CAS :
Molecular Formula : C21H30N2O6
Molecular Weight : 406.47
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
